Randomised Double Blind Placebo Controlled Cross Over Design of the Efficacy of Topical Morphine for Inflammatory Pain in Children With Epidermolysis Bullosa
Information source: Institute of Child Health
Information obtained from ClinicalTrials.gov on June 01, 2007
Link to the current ClinicalTrials.gov record.
Condition(s) targeted: Epidermylosis Bullosa
Intervention: topical opiod (Drug); morphine sulphate in intrasite gel (Drug)
Phase: Phase 4
Status: Completed
Sponsored by: Institute of Child Health Official(s) and/or principal investigator(s):
Richard Howard, Prof, Principal Investigator, Affiliation: Institute of Child Health
Summary
Randomised Double blind placebo controlled cross over design study of the efficacy of morphine for inflammatory pain in children with Epidermolysis Bullosa
Clinical Details
Study design: Interventional, Treatment, Randomized, Double-Blind, Active Control, Crossover Assignment, Efficacy Study
Eligibility
Minimum age: 4 Years.
Maximum age: 18 Years.
Gender(s): Both.
Criteria:
Inclusion Criteria:
- children under 18 years epidermolysis wounds requiring dressing changes
Locations and Contacts
Great Ormond Street Hospital and the Institute of Child health, London WC1N 1EH, United Kingdom
Additional Information
Last updated: October 11, 2006
|
